(vianews) - neoen (neoen.pa), sparebank 1 sr-bk (srbnk.ol), medistim (medi.ol) are the highest sales growth and return on equity stocks on this list.
here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. may these stocks be a good medium-term investment option?
1. neoen (neoen.pa)
48.5% sales growth and 7.39% return on equity
neoen s.a., an independent renewable energy production company, engages in the development and operation of renewable energy power plants. the company operates through solar power, wind power, storage, farm-down, development and investments, and eliminations segments. it operates in argentina, australia, canada, ecuador, the united states, finland, france, ireland, italy, jamaica, mexico, mozambique, portugal, el salvador, sweden, and zambia. neoen s.a. was incorporated in 2008 and is headquartered in paris, france. neoen s.a. operates as a subsidiary of impala sas.
earnings per share
as for profitability, neoen has a trailing twelve months eps of €0.34.
pe ratio
neoen has a trailing twelve months price to earnings ratio of 80.35. meaning, the purchaser of the share is investing €80.35 for every euro of annual earnings.
the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.39%.more news about neoen.
2. sparebank 1 sr-bk (srbnk.ol)
20.5% sales growth and 12.1% return on equity
sparebank 1 sr-bank asa, together with its subsidiaries, provides various financial products and services for personal and corporate customers in southern and western norway. the company operates through retail customers, sme & agriculture, and large corporates segments. it offers its products and services in the areas of savings, loans, insurance, and pensions. the company also provides foreign exchange, administrative securities, commercial properties, leasing, accounting, advisory, estate agency, payroll/hr, securities trading, and investments services; green loans; credit and debit cards; consulting; and banking services. in addition, it facilitates debt and equity funding; and sells real estate properties comprising holiday homes, new builds, and used homes. further, the company is involved in the customer trading of interest rate instruments; and purchasing of home mortgages. it also serves retail and corporate, small business, and agricultural customers, as well as the public sector. the company was founded in 1839 and is headquartered in stavanger, norway.
earnings per share
as for profitability, sparebank 1 sr-bk has a trailing twelve months eps of kr13.32.
pe ratio
sparebank 1 sr-bk has a trailing twelve months price to earnings ratio of 9.49. meaning, the purchaser of the share is investing kr9.49 for every norwegian krone of annual earnings.
the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.1%.yearly top and bottom value
sparebank 1 sr-bk's stock is valued at kr126.40 at 22:20 est, under its 52-week high of kr131.90 and way higher than its 52-week low of kr98.65.
growth estimates quarters
the company's growth estimates for the ongoing quarter and the next is 45.2% and 17.4%, respectively.dividend yield
according to morningstar, inc., the next dividend payment is on apr 14, 2023, the estimated forward annual dividend rate is 7 and the estimated forward annual dividend yield is 5.43%.
more news about sparebank 1 sr-bk.
3. medistim (medi.ol)
16.7% sales growth and 31.89% return on equity
medistim asa develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the united states, europe, asia, and internationally. it offers miraq cardiac, a system that combines ultrasound imaging and transit time flow measurement (ttfm) in a single system for cardiac surgery; miraq vascular, a system that combines ultrasound imaging and transit ttfm in a single system for vascular surgery; and imaging probes for intraoperative use. the company also provides various flow probes, such as quickfit ttfm probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; vascular ttfm probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. in addition, it distributes and sells third party medical equipment. the company was incorporated in 1984 and is headquartered in oslo, norway.
earnings per share
as for profitability, medistim has a trailing twelve months eps of kr6.31.
pe ratio
medistim has a trailing twelve months price to earnings ratio of 38.19. meaning, the purchaser of the share is investing kr38.19 for every norwegian krone of annual earnings.
the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.89%.more news about medistim.
4. tipiak (tipi.pa)
13.7% sales growth and 6.82% return on equity
tipiak société anonyme, a food company, manufactures prepared food products, frozen ready-meals, pastry products, groceries, and crusty bread products. the company offers groceries, such as breadcrumbs, cereals, couscous, croutons, japanese pearls, potato starch, quinoa, and tapioca; frozen products, including savory products, appetizers, and side dishes with grains; and frozen sweet products comprising macarons, mini eclairs, and petits fours. it sells its products in france, england, and the united states. the company was founded in 1830 and is based in saint-aignan-grandlieu, france.
earnings per share
as for profitability, tipiak has a trailing twelve months eps of €4.62.
pe ratio
tipiak has a trailing twelve months price to earnings ratio of 12.55. meaning, the purchaser of the share is investing €12.55 for every euro of annual earnings.
the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.82%.volume
today's last reported volume for tipiak is 1 which is 96.87% below its average volume of 32.
more news about tipiak.
5. jæren sparebank (jaren.ol)
6.2% sales growth and 9.2% return on equity
jæren sparebank provides various financial products and services in norway. it offers accounts; bank guarantees, construction loans, overdrafts, leasing services, and corporate loans; payment and cards services; and savings and pension products. the company also provides liability, health, personal, occupational injuries, travel, accident, business, shop, property, craft, commercial, landlord, and vehicle insurance products, as well as insurance for farm building agriculture, and operating tools and crops. it serves construction, property, trade and services, and agriculture industries. the company is headquartered in bryne, norway.
earnings per share
as for profitability, jæren sparebank has a trailing twelve months eps of kr21.
pe ratio
jæren sparebank has a trailing twelve months price to earnings ratio of 12.1. meaning, the purchaser of the share is investing kr12.1 for every norwegian krone of annual earnings.
the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.2%.volume
today's last reported volume for jæren sparebank is 36 which is 78.94% below its average volume of 171.
more news about jæren sparebank.